FACULTY OF CONFLICT AND CATASTROPHE MEDICINE OF THE WORSHIPFUL SOCIETY OF APOTHECARIES OF LONDON
The Faculty organises part-time courses in Conflict & Catastrophe Medicine, provides funding for undergraduates to participate in these courses, and arranges joint meetings and seminars.
Financial health, per its FY2025 accounts
The accounts state that free reserves increased to £89,362, up from £77,147 in the prior period, with the governors intending to build larger reserves to fund future activities. The charity is fundamentally reliant on the continued support of the Worshipful Society of Apothecaries of London for office space, resources, and administrative staff, which are provided at minimal cost.
What the accounts disclose
Trustees
- AIR VICE-MARSHAL AROOP KUMAR MOZUMDER
- DEREK WESTWOOD ADAMS
- DR CHARLES MACKWORTH-YOUNG
- DR J E NEILD
- Dr DAVID BARRINGTON JEFFERYS
- Dr JOHN CHRISTOPHER MOORE GILLON
- Dr JONATHAN JAMES CORNELIUS HOLLIDAY CVO
- Dr Lee Nigel Winter-Dean
- Dr PEADAR O'MORDHA
- Dr ROY NEWBERRY PALMER
- Dr Timothy David Baker
- Dr Timothy John Villiers Yates
- PROFESSOR JANE ANDERSON
- PROFESSOR MARTIN NEIL ROSSOR
- PROFESSOR MICHAEL JOHN GODFREY FARTHING
- Prof Fiona Jane Wilcox
- Prof Luigi Gerard Anthony Martini
- Professor Christopher Martin Nutting
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/08/2025 | £45k | £38k |
| 31/12/2024 | £59k | £69k |
| 31/12/2023 | £52k | £97k |
| 31/12/2022 | £64k | £89k |
| 31/12/2021 | £77k | £69k |
Common questions
Is FACULTY OF CONFLICT AND CATASTROPHE MEDICINE OF THE WORSHIPFUL SOCIETY OF APOTHECARIES OF LONDON financially healthy?
Per its FY2025 accounts: The accounts state that free reserves increased to £89,362, up from £77,147 in the prior period, with the governors intending to build larger reserves to fund future activities. The charity is fundamentally reliant on the continued support of the Worshipful Society of Apothecaries of London for office space, resources, and administrative staff, which are provided at minimal cost. Its FY2025 accounts were independently examined.